pages/clinical.md
... ...
@@ -8,8 +8,8 @@ link-citations: true
8 8
9 9
## Therapeutic targets
10 10
11
-|Gene|Status|Entity|Therapy|Biomarker?|
12
-|-|-|-|-|-|
11
+|Gene|Status|Entity|Therapy|Biomarkers|
12
+|-|-|-|-|:-----:|
13 13
|[BCL2](/BCL2)|not approved|DLBCL|venetoclax|Not applicable|
14 14
|[BTK](/BTK#clinical-relevance)|not approved|DLBCL|ibrutinib|ABC gene expression signature, MCD genetic subgroup|
15 15
|[CD79B](/CD79B#clinical-relevance)|FDA approved|DLBCL|polatuzumab vedotin|ABC gene expression signature|